D Kleczkowski

1.4k total citations
8 papers, 454 citations indexed

About

D Kleczkowski is a scholar working on Genetics, Immunology and Surgery. According to data from OpenAlex, D Kleczkowski has authored 8 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 4 papers in Immunology and 3 papers in Surgery. Recurrent topics in D Kleczkowski's work include Helicobacter pylori-related gastroenterology studies (3 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). D Kleczkowski is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (3 papers), Inflammatory Bowel Disease (3 papers) and Microscopic Colitis (2 papers). D Kleczkowski collaborates with scholars based in Sweden, France and United Kingdom. D Kleczkowski's co-authors include Zsolt Tulassay, Kjell–Arne Ung, James M. Scheiman, Henrik Ahlbom, Nimish Vakil, Neville D. Yeomans, L Szczepański, Christopher J. Hawkey, Nicholas J. Talley and J. Næsdal and has published in prestigious journals such as Gastroenterology, Gut and The American Journal of Gastroenterology.

In The Last Decade

D Kleczkowski

8 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D Kleczkowski Sweden	6	230	143	135	128	85	8	454
D. Graham United States	7	259 1.1×	108 0.8×	219 1.6×	27 0.2×	33 0.4×	18	480
Huifang Xiong China	10	227 1.0×	57 0.4×	38 0.3×	31 0.2×	48 0.6×	38	393
M Shield United Kingdom	10	205 0.9×	54 0.4×	284 2.1×	22 0.2×	134 1.6×	15	608
Henry W. Kao United States	8	220 1.0×	111 0.8×	43 0.3×	40 0.3×	322 3.8×	9	646
Akihito Ehara Japan	11	402 1.7×	379 2.7×	159 1.2×	75 0.6×	37 0.4×	21	671
L. Lombardo Italy	13	390 1.7×	255 1.8×	27 0.2×	30 0.2×	126 1.5×	23	653
A Zifroni United States	6	133 0.6×	32 0.2×	72 0.5×	91 0.7×	264 3.1×	7	458
C Smyth Ireland	9	110 0.5×	29 0.2×	27 0.2×	121 0.9×	61 0.7×	21	377
Selahattin Ünal Türkiye	13	414 1.8×	146 1.0×	11 0.1×	46 0.4×	149 1.8×	34	677
Misako Takashima Japan	7	448 1.9×	180 1.3×	31 0.2×	17 0.1×	61 0.7×	21	587

Countries citing papers authored by D Kleczkowski

Since Specialization

Citations

This map shows the geographic impact of D Kleczkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Kleczkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Kleczkowski more than expected).

Fields of papers citing papers by D Kleczkowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Kleczkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Kleczkowski. The network helps show where D Kleczkowski may publish in the future.

Co-authorship network of co-authors of D Kleczkowski

This figure shows the co-authorship network connecting the top 25 collaborators of D Kleczkowski. A scholar is included among the top collaborators of D Kleczkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Kleczkowski. D Kleczkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Assche, Gert Van, Francesco Manguso, José Luis Cabriada, et al.. (2015). Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study. The American Journal of Gastroenterology. 110(5). 708–715. 44 indexed citations

2.

Danese, Silvio, Wolfgang Brandt, Laurent Peyrin‐Biroulet, et al.. (2014). Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study. Gut. 64(2). 243–249. 123 indexed citations

3.

Danese, Silvio, Wolfgang Brandt, Jean‐Louis Dupas, et al.. (2014). 863 Tralokinumab (CAT-354), an Interleukin 13 Antibody, in Moderate to Severe Ulcerative Colitis: A Phase 2A Randomized Placebo-Controlled Study. Gastroenterology. 146(5). S–149. 3 indexed citations

4.

Danese, Silvio, Wolfgang Brandt, Laurent Peyrin‐Biroulet, et al.. (2014). OP011 Tralokinumab (CAT-354), an interleukin 13 antibody, in moderate to severe ulcerative colitis: A phase 2 randomized placebo-controlled study. Journal of Crohn s and Colitis. 8. S7–S8. 7 indexed citations

5.

Scheiman, James M., Neville D. Yeomans, Nicholas J. Talley, et al.. (2006). Prevention of Ulcers by Esomeprazole in At-Risk Patients Using Non-Selective NSAIDs and COX-2 Inhibitors. The American Journal of Gastroenterology. 101(4). 701–710. 212 indexed citations

6.

Dítě, Petr, et al.. (2003). Detection of GAD-Ab index in diabetic patients using 35S labeled recombinant human GAD65 antigen. 23(2). 82–86. 4 indexed citations

7.

Tulassay, Zsolt, Petr Dítě, D Kleczkowski, et al.. (2001). One week of treatment with esomeprazole-based triple therapy eradicates Helicobacter pylori and heals patients with duodenal ulcer disease. European Journal of Gastroenterology & Hepatology. 13(12). 1457–1465. 55 indexed citations

8.

Tulassay, Zsolt, et al.. (2000). 7-day treatment with esomeprazole-based triple therapy eradicates H. pylori (Hp) and heals patients with duodenal ulcer (DU) disease. Gastroenterology. 118(4). A502–A502. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact